Robert W. Dubois, MD, PhD

The authors examined the latest trends in development, implementation, and evaluation of care pathways and the impact of the movement toward value-based care.

We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.

Gaps in accountable care measure sets can be addressed efficiently using priority measure types and innovative approaches to measurement.

A decision-making framework that can be used to harmonize the evidence payer's desire for coverage and formulary decisions with the evidence generated by researchers.

Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.

A framework for researchers, providers, payers, or public health bodies identifies when it is most critical to distinguish between "average" population and individual patient response.

A framework for the role of pharmaceuticals in value-based healthcare, practical examples from organizations that have made the transition, and implementation considerations.